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Abstract 
Chronic pain costs up to $635 billion dollars annually and impacts 25.3 million adult U.S. 
citizens (Nahin, 2015). Treatment options have typically included opioid medications, which 
potentially causes harm with long-term use and has contributed to an epidemic of opioid misuse. 
Treatment has expanded beyond monotherapy to include holistic approaches to health, such as 
occupational therapy and mental health therapy. The present study sought to evaluate the 
effectiveness of group therapy as it is conducted in a rural Oregon clinic using the Quadruple 
Aim to measure treatment outcomes (Bodenheimer, & Sinsky, 2014). Participants diagnosed 
with chronic pain and placed on an opioid contract by their primary care provider were mandated 
to attend four weeks of one hour group therapy which included expectations for healthcare 
practices between sessions, and participants were asked to complete a packet of mental health 
screeners before and after treatment. Additional financial data regarding participant spending on 
medical costs was analyzed. Researchers expected participants’ screener scores to improve and 
financial expenditures to decrease overall. Results suggested that group participation was not 
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significantly correlated with subjective support of pain, although their medical costs decreased 
compared to a matched sample of peers who did not attend group therapy. Ultimately, the 
patients and clinic will benefit from ongoing research designed to improve patient satisfaction 
while continuing to maintain cost effectiveness. One option discussed to engage in individual 
therapy to supplement group therapy. Future research is encouraged to incorporate provider 
satisfaction as a means of better utilizing the Quadruple Aim, and to revisit the experimental 
design as to include true control and experimental groups thereby allowing variables to be 
independently evaluated and stronger conclusions to be drawn regarding the effectiveness of 
group therapy. 
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Chapter 1 
Introduction 
 
Chronic pain is a massive problem facing the United States. It is a daily reality for 25.3 
million adults in the United States (Nahin, 2015) and costs the United States $635 billion dollars 
annually (Gaskin & Richard, 2012). Broken down farther according to Gaskin and Richard, 
“Health care costs due to pain ranged from $261 billion dollars…[and] the value of lost 
productivity due to pain ranged from $299 billion to $335 billion dollars annually,” (2012, p. 
715. If unattended, chronic pain could cripple the United States financially and drive up the 
national debt given that the costs associated with CP are anticipated to grow 1.2% faster than the 
United States’ Gross Domestic Product until the year 2025 (Firth, 2017). 
This costly phenomenon is not confined to the United States. Research suggests the 
prevalence of chronic pain is even greater in Canada, Great Britain, the Netherlands, and Sweden 
(Manchikanti, Singh, Datta, Cohen, & Hirsch, 2009). Research conducted by the Global Burden 
of Disease, utilizing a systematic analysis of over 250 diseases and conditions that cause 
disability worldwide, suggested low back pain and neck pain were two of the leading causes of 
disability on a global scale (Vos et al., 2012). Another study led by the Global Burden of Disease 
sought to understand and project worldwide spending patterns on healthcare through the year 
2040. They found that wealthier countries were projected to increase spending on healthcare at a 
level disproportionately greater than lower-income countries (Global Burden of Disease Health 
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Financing Collaborator Network, 2017). Given the disparate projected spending patterns, it is 
likely that many countries will be unable to efficiently meet the health needs of their population. 
Pervasive Impact of Chronic Pain 
While it is difficult to identify the precise cost of chronic pain, it is undeniable that 
chronic pain is deleterious to the individual’s overall quality of life (Phillips, 2009). Multiple 
studies indicate that physical and mental symptoms occurring in tandem with chronic pain are 
associated with increased risk for mortality, poorer quality of life and more frequent urgent care 
or emergency department visits (Nunes, Flores, Mielke, Thume, & Facchini, 2016). Patients with 
these coexisting conditions account for the 45-65% increase in healthcare spending (Thrope, 
Ogden, & Galactionova, 2010).  
Two of the most common mental health disorders associated with chronic pain are 
posttraumatic stress disorder (PTSD) and depression (Outcalt et al., 2015). In addition to a 
potentially reciprocal influence on pain, PTSD and major depressive disorder have a significant 
impact on overall functioning and quality of life (Outcalt et al., 2015). Additionally, prior 
research has suggested that patient mood may be confounded by the impact of chronic pain on 
sleep. Pain detracts from sleep and poor sleep in turn contributes to increased pain experiences 
(Marty et al., 2008). Not only does chronic pain impact individual’s psychological wellbeing, it 
is also implicated in an individual’s physical wellbeing. Research has highlighted that the 
combination of chronic pain and clinical depression is a predictive factor for fall risk in geriatric 
populations (Eggermont, L., Pennix, B., Jones, R., & Leveille, S., 2012). These findings suggest 
that treating pain and concurrent mood related concerns may affect multiple aspects of 
biopsychosocial functioning. 
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While studies have shown that people with chronic pain who are partnered may fare 
better than their single counterparts (Taylor, Davis, & Zautra, 2012), pain has been shown to 
negatively impact the partners of those with chronic pain (West, Usher, Foster, & Stewart, 2012). 
According to Wethington (2015), chronic pain affects marital quality, intimate relationship 
functioning, and overall social integration. Furthermore, adults who report chronic pain also 
report poorer sexual functioning and poorer perceived health overall (Wethington, 2015). The 
negative repercussions of chronic pain are not reserved for only the patient and their partner. 
Family members of people with chronic pain are also impacted. On average they report feeling 
powerless, alienated, emotionally distressed and distant as a family unit (West et al., 2012). 
Taken together, the systemic impact of chronic pain has increased the urgency to develop 
effective treatment for this complex condition.  
Treatment Approaches 
The healthcare industry is caught between two interrelated crises; the crisis of chronic 
pain and the crisis of opioid misuse and overdose (Krashin, Murinova, & Sullivan, 2016). As the 
most common allopathic treatment modality for chronic pain, opioid medications are merely 
effective in reducing acute pain, though long-term efficacy is lacking (Shaheed, Maher, 
Williams, Day, & Mclachlan, 2016). Long-term opiate use is often associated with a range of 
side effects, such as nausea, constipation, and tolerance/addiction (Raghavan & Humble, 2011). 
Additional studies have found a wide range of chronic health conditions associated with long-
term opiate use including hypogonadism, osteoporosis, immune suppression, cognitive 
impairment, and hyperalgesia, as well as heightened response reflex to noxious stimuli (2011). 
Furthermore, there has been a 124% unintentional drug overdose increase from 1999-2007, 
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largely due to prescription-related opioid overdoses (Okie, 2010). This increase in opioid-related 
deaths has led to policy makers enforcing stringent prescribing practices, as observed in standard 
care practices within the State of Oregon. Specifically, patient morphine equivalency doses 
(MED) can no longer exceed 100-milligrams within five years in the state of Oregon (2010). In 
an observation that pre-dates the current opioid misuse epidemic, Henry McQuay (2008) 
observed that chronic pain is low on political priority lists and deserves more attention from our 
elected officials. He continued to say chronic pain puts people “at the bottom of the pile.” 
making the need evident for professional advocacy in order to attain a “fairer share of the 
medical resource cake,” (2008, p. 38). 
Multidisciplinary approaches have been shown to reduce costs and result in a higher 
quality of care for patients with chronic pain (Crosson, 2009). Research in the last 10 years has 
clearly shown that chronic pain is best treated using an interdisciplinary approach, including 
behavioral health, pharmacologic and nonpharmacologic self-management interventions 
(Tompkins, Hobelmann, & Compton, 2017). Given the myriad of mental health symptoms 
associated with chronic pain, it follows that behavioral health services are an important 
component of the interdisciplinary chronic pain treatment team. Behavioral health treatments 
typically involve interventions by a behavioral health consultant who has been trained with a 
cognitive-behavioral therapy (CBT) modality (Jensen, 2011). Research conducted by Possemato 
et al. (2018) relevant to a systemic approach in treating primary care has shown the efficacy of 
Primary Care Behavioral Health (PCBH) services, including higher levels of patient engagement 
in care, improved patient satisfaction, and shorter wait-times. While it is known that 
collaborative care models improve mental and physical health, such as chronic pain, the 
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effectiveness may vary (Beck et al., 2018), posing a problem for clinicians. In contrast, there is 
consistent evidence to support collaborative care models as potentially cost-effective treatment 
approaches for people with mental and physical co-existing conditions including chronic pain 
(Cemacho et al., 2018). Towards that end, one relevant domain of cost savings is the reduced 
expenditure in out-patient mental health specialty services that occurs when patients receive 
integrated behavioral health services within the primary care clinic (Leung et al., 2017). 
Non-pharmacological treatments include alternative medicine and behavioral health 
interventions, and are often referred to as complementary and alternative medicine (CAM) 
therapies. Alternative medicine approaches consider massage therapy, physical therapy, and 
acupuncture viable treatment options (Vickers et al., 2012). The National Center for 
Complementary and Integrative Health (NCCIH) divides CAM into two categories, mind and 
body therapies (e.g., yoga, exercise, relaxation techniques) and natural products (e.g., herbs and 
vitamins; NCCIH, 2017). Given comorbid health issues arising from chronic pain, as well as 
strides to emphasize holistic health approaches, other fields (e.g., occupational therapy, physical 
therapy, and psychology) are tantamount in providing optimal care.  
To further complicate treatment for chronic pain, there are pain presentations not 
responsive to first line treatments, such as systemic drug delivery options and physical therapy. 
When conventional methods are ineffective toward treating chronic pain, it is considered 
“refractory pain,” (Chaverneff, 2016). According to Chaverneff, spinal cord stimulation and 
interventional therapy (IT) may be effective treatments for refractory pain (2016). Interventional 
therapy is an invasive procedure in that medications are directly injected to areas of concern, 
theoretically lessening the potential for overdose (Chaverneff, 2016). However, other studies 
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have called the efficacy of interventional therapy into question, proposing that IT effects are 
uncertain given the inborn risk and high cost of interventional therapy (Ko & Kim, 2012, June). 
Another option to treat refractory pain may be transcranial magnetic stimulation. According to 
Cheng (2013), transcranial magnetic stimulation may be able to reduce pain transmission across 
the spinal cord (2013). Other studies have shown that 20 minutes of transcrainial magnetic 
stimulation increases pain thresholds in some participants (Taylor et al., 2013). The relatively 
high cost and variability in outcome highlights the need for multi-disciplinary treatment that are 
more affordable and accessible.  
The “Triple Aim” as defined by McCarthy and Klein (2010) is a policy designed to 
enrich patient experience of care with respect to quality and satisfaction, the overall health of the 
general population and the cost of care. Financial expenditures and patient health are two integral 
components of the “Triple Aim,” (McCarthy & Klein, 2010). More recently, pundits in the 
healthcare community have advocated for the addition of a fourth component, provider 
satisfaction. The goal of the fourth component is “to minimize physician burnout,” thereby 
ensuring a stable workforce as chronic health conditions continue to rise. Including the fourth 
component is particularly relevant for providers treating patients with chronic pain. Research has 
highlighted that treating chronic pain induces feeling of frustration and powerlessness in both 
provider and patient as it is often a recalcitrant condition. As such, opting for the Quadruple Aim 
in lieu of the Triple Aim (Bodenheimer, & Sinsky, 2014) may be particularly relevant for 
providers treating patients with chronic pain. Ultimately, the Quadruple Aim initiative provides a 
framework to evaluate the effectiveness of multidisciplinary approaches to chronic pain. 
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Current research supports the use of group therapy, in addition to individual therapy, as a 
treatment modalities for chronic pain (Feng & Catlin, 2016). One group therapy study indicated 
fewer depressive symptoms and less pain interference of their normal activity after treatment 
(Feng & Caitlin, 2016). According to Alizadehfard (2012), chronic pain participants who 
completed long-term group therapy were better able to find adaptive solutions that minimized 
their typical recurrent pain behaviors. In addition, existential psychology-based group therapies 
were also found to be efficacious, as “life review group therapy” for elderly chronic pain 
sufferers’ resulted in significant improvements on pain-related questionnaire scores 
(Alizaderfhad, 2012). 
People living in rural areas experience additional barriers in accessing treatment for 
chronic pain, including limited general and specialty providers, transportation and limited 
financial resources as compared to similar populations living in urban areas. While the efficacy 
of cognitive behavioral therapy is well-documented toward treating common mental disorders, 
access to treatment itself is largely insufficient (Salomonsson et al., 2018). Access limitations 
make treatment in rural settings even more difficult, as a result, rural residents are more likely to 
rely solely on their primary provider for pharmacological treatment and neglect self-management 
interventions. The overreliance on PCPs in rural populations is likely a function of having 
limited access to a network of formally trained providers with expertise in managing pain 
(Mezei, & Murinson, 2011) in conjunction with the proclivity for rural residents to be prescribed 
opioids at higher rates than non-rural residents (Prunuske et al., 2014). This has led to a 
significant disparity in the use of self-management techniques for rural populations (Eaton et al., 
2018). A possible solution to increase access may be found in guided self-help (GSH) cognitive 
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behavioral therapy. GSH cognitive behavioral therapy is a method in which patients meet face-
to-face with a clinician for an initial appointment then may have as few as zero face-to-face 
appointments thereafter, using telehealth instead. GSH cognitive behavioral therapy boasted 
comparable disorder remission rates in 6- and 12-month follow-ups (Salomonsson et al., 2018). 
Other studies have found similar results, supporting the effectiveness of digital behavioral health 
programs in primary care settings. Yu, Szigethy, Wallace, Solano, and Oser (2018) found that 
digitally delivered therapy interventions are associated with reductions in anxiety-related 
symptoms, thereby improving access to patients in need. 
Program Evaluation: The EPIS Model 
Especially within the context of the Quadruple Aim, it is incumbent on healthcare 
providers to systematically develop and assess all patient treatment interventions and programs. 
There are many methods of evaluating the effectiveness of programs, particularly within primary 
care settings. One such method is the EPIS model. EPIS stands for Exploration, Preparation, 
Implementation, Sustainment (Aarons, Hurlburt, & Horwitz, 2011). Per Aarons et al. (2011), 
Exploration refers to the process of considering what evidence-based practices might best solve 
the identified problem, while considering challenges to the outer and inner contextual factors, 
Preparation refers to planning the logistics of how to include the selected practice into the 
existing system, Implementation refers to carrying out the planned intervention, allowing 
implementers opportunity to discern if there are major areas of concern regarding the 
intervention, and Sustainment refers to the ongoing monitoring of the program in terms of quality 
and finances. The California Evidence-Based ClearingHouse for Child Welfare has adopted the 
EPIS model as its primary evidence based implementation framework. Studies have shown that 
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the utilization of the EPIS model improves care for vulnerable populations as it is applied to 
outer service systems and inner organizational contexts simultaneously (Becan et al., 2018). The 
current study used the EPIS model to effectively measure and implement evidence-based 
changes in an existing system. 
Present Study 
Per McQuay (2008, p. 41), “No one thing will improve this (chronic pain) situation. We 
need more and better basic research.” The purpose of the current study was to evaluate the 
effectiveness of the Pain Pathway Program developed and implemented within a small primary 
care practice in a rural Oregon county with the hopes of improving outcome for patients with 
chronic pain. The Pain Pathway Program is the clinic’s response to the ineffectiveness and 
increasing epidemic of opioid misuse in Oregon. The treatment program mandated patients who 
were prescribed opioids to attend four two-hour group therapy sessions over the period of four 
weeks. The sessions reviewed theories of pain, pain’s impact on relationships, coping strategies, 
and associated relaxation techniques. The current study evaluated the effectiveness of this 
program with a dual focus on patient outcome and financial expenditure.  
Researchers expected results to converge with the current body of literature in that group 
therapy is effective at improving patient health and decreasing patient fiscal expenditures. For 
the present study, the following hypotheses were tested:  
 Hypothesis 1: Patients who completed the Pain Pathway Program will have improved 
healthcare outcomes compared to the comparison group 
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 Hypothesis 2: Patients who completed the Pain Pathway Program will spend less money 
on treatment and medical expenses than their peers who did not complete or attend the Pain 
Pathway Program.  
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Chapter 2 
Methods 
Participants 
The current study used archival data from approximately 850 chronic pain patients who 
sought medical attention for chronic pain in one medical clinic within a rural county in Oregon 
(94% Caucasian, 3% Latino/Latina, 3% other; average age of participants was 60.53 years old). 
Participants rated their pain on a scale ranging from 1-10 (1 = little to no pain, 10 = severe pain). 
The average pain rating was 6.38 (SD = 1.74) and participant pain “at its worst” within 24 hours 
of completing the screener was 4.75 (SD = 1.72). However, one-third of participants reported 
their pain “at its worst” as 7/10. Pain was most commonly reported on the back, knees and legs. 
The treatment group (i.e., participants who completed the pain pathway and did pre- and post-
screeners) was comprised of 15 people. Financial data regarding healthcare spending habits was 
gathered for 12 of those 15 people. Insurance claims data was collected for an additional 15 
people who did not complete the requisite group therapy in order to supplement a control group 
in terms of spending patterns. The control group (i.e., the group that did not complete the four 
group therapy sessions and associated screener packets) was 786 people. This group was used to 
ensure the treatment group was representative of the larger pain patient population with respect 
to age, gender, morphine equivalent dose (MED), and ethnicity. There were no specific 
exclusionary criteria once patients were admitted into the Pain Pathway. This research project 
was approved by the Human Subjects Review Committee of George Fox University, Newberg, 
OR. 
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Materials 
Participants completed a combination of screeners, typically upon entering the pain 
pathway. The screeners examined within the pain packet are the Patient Health Questionnaire 
(PHQ-9), Generalized Anxiety Disorder 7-item scale (GAD-7), Brief Pain Inventory-Short Form 
(BPI), and Physical Functional Ability Questionnaire (FAQ-5).  
 The Patient Health Questionnaire. The Patient Health Questionnaire (PHQ-9) assesses 
depression using a 9-point Likert scale. This measure has been shown to accurately predict 
depression, as evidenced by 7.0-13.6 percent increase in the odds of depression among people 
with elevated PHQ-9 scores (Kroenke, Spitzer, & Williams, 2001). For the present study, not all 
items were collected for the PHQ-9 and thus the data was prorated for analysis purposes. See 
Appendix A. 
 The Generalized Anxiety Disorder Screener. The Generalized Anxiety Disorder 
Screener (GAD-7) is used to assess anxiety using a 7-point Likert scale. The GAD-7 has a 0.83 
test-retest reliability and significant concurrent validity compared with the Beck Anxiety 
Inventory (r = .072; Lowe et al., 2008). For the present study, not all items were collected for the 
GAD-7 and thus the data was prorated for analysis purposes. See Appendix B. 
 The Brief Pain Inventory-Short Form (BPI). The Brief Pain Inventory-Short Form 
(BPI) is a measure used to assess pain levels. The nine questions on the BPI evaluates severity of 
pain, the impact of pain on daily function, the location of pain, pain medications, and the amount 
of pain relief in the past 24-hours. The BPI has acceptable internal consistency, construct 
validity, criterion validity, and high test-retest reliability (Stanhope, 2016). For example, internal 
consistency reliability (Cronbach's α) was greater than 0.80 for the BPI according to Kapstad, 
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Rokne, and Stavem (2010). For the present study, not all items were collected for the BPI and 
thus the data was prorated for analysis purposes. See Appendix C. 
 The Physical Functional Ability Questionnaire (FAQ5). The Physical Functional 
Ability Questionnaire (FAQ5) is a 5-question tool measuring a participant's functioning in 
activities of daily living (e.g., walking up a set of stairs without assistance). Participants rank 
from 0-4 how impaired they are in the following domains: self-care, chores/social activities, 
walking/stairs, lifting, and work; scores of zero infer complete impairment and four’s indicate 
lack of impairment. Patient responses were calculated to extrapolate an approximate percentage 
of impairment. The FAQ5 appears to have reasonable face validity as all questions directly 
pertain to participant’s functioning. For the present study, not all items were collected for the 
FAQ5 and thus the data was prorated for analysis purposes. See Appendix D. 
 Pain risk numbers. The Pain Risk Number is an in-house measurement of the likelihood 
of someone abusing prescription opioid medications. It is a weighted number out of 10 computed 
by a computer algorithm. Quarterly urine analysis, previous substance use history, current 
alcohol use, presence of a sleep apnea diagnosis, current or previous prescriptions of other 
opiates, methadone or benzodiazepines, and other previous or current psychiatric diagnoses are 
factors used in the calculation of an individual’s pain risk number. These numbers were 
calculated by staff members and pain specialists within the clinic. 
 The morphine equivalent dose. The Morphine Equivalent Dose (MED) is a numerical 
measurement against which all opioids can be compared in terms of pain relief. Understanding 
MED’s allows doctors and patients to measure opioid doses as either effective or excessive, in 
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addition to aiding in decision making processes when considering transitioning from one opioid 
to another.  
 Financial claims data. Financial claims data was provided to the researchers by the 
health plan’s Business Intelligence Specialist (see Procedure), and researchers analyzed the 
amount of money patients spent on office visits, inpatient stays, outpatient services, emergency 
department visits, lab costs, and overall facilities costs. In order to appropriately compare means 
before and after treatment, data was pulled six months prior to a patient’s entry into the Pain 
Pathway and then for the six-month period after they completed the requisite four group therapy 
sessions. Similarly, a control group was established by pulling six months of claims data for 
patients who met with a pain coordinator but did not attend the requisite group therapy. 
Procedure 
Participants signed an informed consent acknowledging their electronic health 
information and responses to the pain screener packets may be used for research purposes. 
Participants who agreed to the informed consent policy then met with a Pain Coordinator to 
assess their risk of abusing opioid medications. At this time, the Pain Coordinator provided 
participants the pain screener packets and divided them between “Pain High” and “Pain Low” 
groups. Participants were placed into the Pain High group if they met the following criteria: 
prescription is equal to or greater than 40 MED, use of methadone and/or benzodiazepines, 
history of psychological diagnosis (past or present), and sleep apnea. Participants were placed in 
the Pain Low group if they met the following criteria: prescription is an MED score lower than 
40 and no other reported risk factors. Participants were placed in the “Pain Observation” group if 
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they met the following criteria: an MED score of 15 or less, managed psychological diagnosis 
(i.e., in treatment/remission), managed sleep apnea, and no methadone or benzodiazepine use.  
Participants in the Pain High category were required to attend four group psychotherapy 
sessions where they learned about chronic pain, current theories on pain, pain’s impact on 
relationships, coping strategies, and relaxation techniques. Pain Low participants were given the 
option to engage in the Pain Pathway groups. All participants (i.e., both Pain High and Pain 
Low), were required to meet with a Pain Coordinator quarterly the entire time they were 
prescribed opioids. The Pain Coordinator provided the same measures from the initial pain 
screener packet to gather post-group data in order to measure the effectiveness of group therapy 
after participants completed their fourth and final group therapy session. To collect participant 
healthcare expenses, researchers gathered patient insurance policy numbers on an encrypted 
spreadsheet. Then researchers hand delivered the encrypted data to the Business Intelligence 
Specialist of the health plan who extracted specific participant expenses from a database.  
Participants were excluded if they were not willing to cease substance or alcohol use, or if they 
were rated as Pain Low and elected to abstain from the Pain Pathway. 
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Chapter 3  
Results 
 
The average age of participants who completed the pain pathway and screeners, aka the 
treatment group, (M = 59.85, SD = 13.05) was comparable to the mean age of participants 
within the comparison group (M = 58.44, SD = 18.02). In other words, the two groups were 
statistically homogenous in terms of age [F(1,844) = .429, p = .51]. Similarly, participant MED 
(t(13.37) = -0.63, p = .05) and Pain Risk (t(68) = 0.39, p = .70) was virtually indistinguishable 
between the treatment and comparison groups. See Tables 1 and 2. 
 
Table 1 
Patient Demographics 
Measure Treatment Comparison 
 x̅ SD x̅ SD 
Age 59.85 13.05 58.44 18.02 
MED 30.23 22.85 48.89 36.30 
Pain Risk     2.18     1.17     1.78     1.30 
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Table 2 
Patient Demographics Part 2 
Demographic data  Treatment  Comparison  
Gender 
 
 
Male  3                               4 
Female 9                             11 
Ethnicity Caucasian 10  13 
   1 
   1 
 
Latino(a) 
Other 
2 
3 
  
 
 
An independent samples t-test was calculated to ensure that the participants whose 
financial data was collected were equitable between groups in terms of age, MED, and Pain Risk. 
Findings suggested no significant difference in terms of age for patients who attended the Pain 
Pathway (M = 49.69, SD = 13.57), and those who did not (M = 46.38, SD = 11.08); t(25) =        
-.669, p = .491). Levene’s test indicated equal variances (F = .39, p = .538) and thus the degrees 
of freedom were not adjusted. There was no significant difference in terms of MED for patients 
who attended the Pain Pathway (M = 30.23, SD = 25.85) and those who did not (M = 48.89, SD 
= 36.30); t(18) = 1.342, p = .20. Levene’s test indicated equal variances (F = .69, p = .42) and 
thus the degrees of freedom again were not adjusted. Lastly, there was no significant difference 
in terms of Pain Risk for those who attended (M = 2.18, SD = 1.17) and those who did not (M = 
1.78, SD = 1.30); t(18) = -.731, p = .47. Levene’s test indicated equal variances (F = .73, p = .41) 
and thus the degrees of freedom were not adjusted. Said another way, the comparison and 
treatment groups were equitable with one another in terms of age, MED, and Pain Risk. 
 Similarly, a Chi-Square test of independence was calculated comparing the frequency of 
distribution of gender and ethnicity between the treatment and comparison groups. No 
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relationship was found between gender and completion of the Pain Pathway in this study, X2(1) = 
.01, p = .922. Again, no relationship was found between ethnicity and the participants of this 
study, X2(2) = 1.41, p = .494. These findings suggested that ethnicity and gender were equally 
represented in both groups. 
         Results on pre and post screeners were analyzed using a paired samples t-test. Not all 
items were collected from the screeners, and therefore data for the PHQ-9, GAD-7, BPI, and 
FAQ-5 were prorated. Results are displayed in Table 3. 
 
Table 3 
Patient Health Screeners 
Measure 	 Pre x̅ Post x̅  Pre SD Post SD    t	 d’ p	
PHQ-9 	 4.14 8.73 3.26 5.07 -2.19	 -.69 .06	
GAD-7 	 3.15 10.85 3.48 6.58 -3.02	 -.95 .02	
FAQ-5 	 71.88 68.75 13.26 0.00 0.33	 .24 .79	
BPI 	 3.76 5.26 2.01 0.49 -2.15	 -.68 .06	
MED 	 30.23 25.27 25.85 21.06 1.38	 .42 .20	
Pain Risk 	 2.00 2.59 1.21 1.39 0.18	 .21 .70	
 
 
Scores on the PHQ-9 resulted in no significant change after treatment, t(9) = -2.19, p = 
.06, however the effect size for the difference between means was moderate, d’ = -.69. There was 
a significant increase in anxiety scores, reflected on the GAD-7, after treatment, t(9) = -1.93, p = 
.02, and a large effect was observed, d’ = -.95. Scores on the FAQ-5 underwent no significant 
change after treatment, t(1) = .33, p = .79, however a small effect size was observed, d’ = .24. 
EFFECTIVENESS OF GROUP THERAPY FOR CHRONIC PAIN  19 
 
 
After treatment, scores on the BPI did not significantly change, t(9) = -2.15, p = .06, and a 
medium effect was observed, d’ = -.68. There was no significant change in patient MED’s after 
treatment, t(10) = 1.38, p = .20, and a small effect of time was observed before treatment and 
after treatment, d’ = .42.  
Non-significant differences in scores were observed regarding patient Pain Risk before 
group therapy (m = 2.00, sd = 1.21) and after group therapy (m = 2.59, sd = 1.39). Additionally, a 
small effect was observed; t(68) = 0.18, p = .70, d = .21. 
 A 2 (times) x 2 (groups) x 6 (cost centers) repeated measures ANOVA was calculated to 
quantify the effect of time, group attendance, and cost centers on money spent for pain 
management. The cost centers were: total costs, office visit, outpatient, emergency department, 
laboratory, and facilities. Sphericity was met for all analyses.  Due to the small sample sizes and 
associated low power, the ANOVA results will not be reported and eta2 will be reported in 
addition. The results are displayed in Table 4.  
No main effect of group was observed, F(1,25)=2.87, p= .10. No significant main effect 
of time was observed, F(1,25)= 2.13, p= .16, and no significant interaction was observed of time 
and group, F(1,25)= 3.55, p= .07. However it should be noted the effect sizes of these factors and 
their interactions are all moderate in size. 
Although the increase in total costs for the comparison group was not significant (t(14) = 
-1.99, p = .07; d = .52), a moderate effect was observed. Interestingly for the treatment group, 
whose findings did not boast significance as well (t(11) = .55, p = .59; d = .15), no effect was 
observed. In other words, participants who did not attend group therapy had large increases in 
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Table 4 
Cost Centers for Treatment and Comparison Groups 
 Treatment group Comparison group 
Measure Mean SD d’ p  Mean SD d’ p η2 
Total pre  973.75 1530.70    925.36 1038.19    
Total post  686.99 1250.43 .15 .59  3189.60 4388.95 .52 .07  
Office pre 570.88 1102.86    619.39 708.58    
Office post 332.36 520.39    892.92 961.62  .28  .05 
Outpatient pre 25.32 66.20    44.34 70.42    
Outpatient post 8.30 22.44    252.93 443.82  .058 .16 
ED pre 91.58 175.68    4.13 16.00    
ED post 45.10 111.85    94.36 195.62  .673 .01 
Lab pre 49.27 83.22    118.38 113.21    
Lab post 51.66 79.49    96.66 129.52  .09 .11 
Facilities pre 236.70 338.05    139.11 239.40    
Facilities post 210.93 519.23    1731.23 3266.39  .15 .08 
 
their expenditures regarding healthcare. However, participants who attended group therapy had 
little to no increase in expenditures. 
Three paired samples t-tests were used to make post hoc comparisons between office visit 
spending patterns. The comparison group’s spending patterns were evaluated at the time of their 
entry into the pain pathway (M = 619.39, SD = 708.58) and six months after their entry (M = 
892.92, SD = 961.62) and the experimental group’s spending patterns were evaluated for the six 
months before entering the pain pathway (M = 570.88, SD = 1102.86) and six months after 
completing the regiment (M = 332.36, SD = 520.39).  There was not a significant main effect of 
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group (treatment and comparison), F(1,25) = 1.23, p = .28, η2 = .05. The eta2 indicates that this 
is a small effect. A second Paired samples t-test indicated no main effect was found with respect 
to time, F(1,25) = .009, p = .93, η2 = .000. A third paired samples t-test indicated a small 
interaction between time and group, F(1,25) = 1.96, p = .174, η2 = .07. 
Three paired samples t-tests were used to make post hoc comparisons between outpatient 
spending patterns. The comparison group’s expenditures were evaluated at the time of their entry 
into the pain pathway (M = 44.34, SD = 70.42) and six months after their entry (M = 252.93, SD 
= 443.82) and the experimental group’s expenditures were evaluated for the six months before 
entering the pain pathway (M = 25.32, SD = 61.87) and six months after completing the 
regiment (M = 8.30, SD = 22.44). A first paired samples t-test indicated that there was not a 
significant difference between groups, however a large main effect was found with respect to 
group attendance, F(1,25) = 3.96, p = .058, η2 = .16. A second paired samples t-test indicated a 
lack of significant difference between the groups, however a moderate main effect was found 
with respect to time, F(1,25) = 2.17, p = .15, η2 = .08. A third paired samples t-test indicated a 
lack of significant difference between the groups, however a moderate interaction was found 
with respect of time and group, F(1,25) = 3.01, p = .10, η2 = .11. Secondary analyses were ran 
to calculate the exact trend of each group’s reaction to the large interaction between groups. 
Results, via a paired samples t-test, suggest that the control group before and control group after 
reacted to the large interaction differently (t(17) = -0.17, p = .86). An independent samples t-test, 
whose variances were assumed (F = .08, p = .16), suggested that the effect sizes support that the 
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control and experimental groups responded to the large interaction of group differently as a 
function of group attendance (t(19) = 1.45, p = .16). 
Three paired samples t-tests were used to make post hoc comparisons between 
emergency department costs. The comparison group’s expenditures were evaluated at the time of 
their entry into the pain pathway (M = 4.13, SD = 16.00) and six months after their entry (M = 
94.36, SD = 195.62) and the experimental group’s expenditures were evaluated for the six 
months before entering the pain pathway (M = 91.58, SD = 175.68) and six months after 
completing the regiment (M = 45.10, SD = 111.85). A first paired samples t-test indicated that 
there was not a significant difference between the control and experimental group and no main 
effect was found with respect to group attendance, F(1,25) = .183, p = .673, η2 = .01. A second 
paired samples t-test indicated a lack of significant difference between groups, however a 
moderate small effect was found with respect to time, F(1,25) = .46, p = .51, η2 = .02; a third 
paired samples t-test indicated a lack of significant difference between the groups, however a 
large interaction was found with respect of time and group, F(1,25) = 4.44, p = .045, η2 = .15. 
Three paired samples t-tests were used to make post hoc comparisons between lab costs. 
The comparison group’s spending patterns were evaluated at the time of their entry into the pain 
pathway (M = 118.38, SD = 113.20) and six months after their entry (M = 96.67, SD = 129.52) 
and the experimental group’s spending patterns were evaluated for the six months before 
entering the pain pathway (M = 49.28, SD = 83.22) and six months after completing the 
regiment (M = 51.66, SD = 79.49). A first paired samples t-test indicated that there was not a 
significant difference between groups, however a moderate main effect was found with respect to 
group attendance, F(1,25) = 3.08, p = .09, η2 = .11. A second paired samples t-test indicated a 
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lack of significant difference between the groups, however a small main effect was found with 
respect to time, F(1,25) = .15, p = .702, η2 = .01. A third paired samples t-test indicated a lack 
of significant difference between the groups, however found no interaction of time and group, 
F(1,25) = .22, p = .63, η2 = .009. 
Three paired samples t-tests were used to make post hoc comparisons between facilities 
costs. The comparison group’s spending patterns were evaluated at the time of their entry into 
the pain pathway (M = 139.11, SD = 239.40) and six months after their entry (M = 1731.23, SD 
= 3266.39) and the experimental group’s spending patterns were evaluated for the six months 
before entering the pain pathway (M = 236.70, SD = 338.05) and six months after completing 
the regiment (M = 210.93, SD = 519.23). A first paired samples t-test indicated that there was 
not a significant difference between groups, however a moderate main effect was found with 
respect to group attendance; F(1,25) = 2.18, p = .15, η2 = .08. A second paired samples t-test 
indicated a lack of significant difference between the groups, however a moderate main effect 
was found with respect to time, F(1,25) = .2.65, p = .116, η2 = .10. A third paired samples t-test 
indicated a lack of significant difference between the groups, however found a moderate 
interaction of time and group, F(1,25) = 2.83, p = .11, η2 = .10. 
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Chapter 4 
Discussion 
 
The present study sought to evaluate the effectiveness of group therapy as a treatment for 
chronic pain as conducted at a medical clinic in rural Oregon. Participants completed a 
combination of screeners before and after completing four separate group therapy sessions. 
Additionally, their financial expense patterns were recorded and analyzed before and after 
completing the group therapy requirements. The first hypothesis tested predicted patient 
screeners would show improved overall quality of health after group therapy. The second tested 
hypothesis predicted that participants who attended the Pain Pathway would spend less money 
on medical care after completing the program. Scores on most health screeners showed a trend 
toward worsening after treatment, however these changes cannot be ruled out due to random 
chance. Scores on an anxiety measure were significant and showed worse anxiety symptoms 
after treatment. This conclusion contradicts current research regarding the effectiveness of group 
therapy and converged with research acknowledging the high degree of variability in 
multidisciplinary settings. Secondly, patient MED, Pain Risk numbers, and health screener 
scores did not result in significant change after treatment for the treatment group. Findings 
illustrated decreases in spending over time which converged with the current literature stating 
that group therapy and PCBH decrease financial burden for patients, particularly in rural settings. 
As measured by the Triple Aim, this program does not significantly influence patient health 
screeners and thereby does not bolster patient health outcomes. As such, researchers failed to 
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reject the null hypothesis. However, more data will be needed to draw decisive conclusions given 
the discrepancy between patient self-report measures and financial data. 
As stated, patient health screeners appeared to be associated with, although lack of 
statistical significance would indicate the necessity to increase power or sample size, worse 
scores after treatment overall. That said, according to the effect sizes, the symptoms assessed 
PHQ-9 and BPI worsened by a moderate degree (effect sizes go here) after treatment, the 
symptoms assessed by the GAD-7 worsened by a large degree (effect sizes go here), and the 
symptoms assessed by the FAQ-5 worsened by a small degree. Moreover, according to effect 
sizes scores, on the PHQ-9 went from none to mild after treatment, GAD-7 scores went from 
“none” to moderate, and scores on the BPI were within the mild range prior to treatment and 
were in the moderate range after treatment, according to the cutpoints for the BPI as posited by 
Kapstad, Hanestad, Langeland, Rustoen, and Stavem (2008). This study failed to reject the null 
hypothesis regarding patient health outcomes as represented by health screeners. 
The lack of support for the effectiveness of the group may have been influenced by a 
negative contagion in the group setting. In other words, since participants may have been 
resentful they were mandated to attend treatment to receive their previously prescribed pain 
medication. This resentment may have been exacerbated by the broad directive that mandated 
providers reduce the MED prescription regardless of patients’ demonstrated responsibility in 
using medication. Screener results were not consistent with the current body of literature, nor 
what researchers expected to find regarding group therapy as a largely positive influence in 
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patient health outcomes. Again, the small quantity of patients who attended group therapy and 
completed post-treatment screeners may have contributed to the lack of significant results.  
MED likely decreased as a function of statewide policy, explaining the observed small 
effect of time on MED decreases. This mandatory decrease in medication dose, while enhancing 
patient safety, likely contributed to patient dissatisfaction illustrated via other measures (e.g., 
scores on PHQ-9, GAD-7, etc.). Although at a first glance, the program may not be seen as 
positively affecting patient experience, it is important to note that patient’s mood or perception 
of function did not decrease even as their MED was decreased. Some patients with chronic pain 
may catastrophize that if their pain medication is reduced, they will experience a significant 
increase in mental health symptoms and pain interference. The expected increase in impairment 
simply did not happen in this group. Given the quasi-experimental nature of the design, it is 
impossible to determine if the symptom stabilization in the face of opioid reduction was due to 
group participation or gradual adjustment to decrease in MED. Ongoing stabilization may be the 
first step on a gradual improvement in mood and functioning as patients are tapered to lower 
MED. It is possible that patient satisfaction will increase as populations become more 
accustomed to the new prescription practices and alter medication expectations accordingly. 
The cost centers examined for this study were overall costs, office visits, outpatient, 
emergency department, lab, and facilities. Three cost centers improved for people who 
completed the program and three cost centers remained the same after treatment for those who 
completed the program. This is in contrast to the comparison group, where financial costs 
regardless of cost centers. In other words, patients who did not attend the Pain Pathway had 
significant increases in financial costs in all domains whereas patients that did attend had little or 
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no increase in financial costs. These financial differences are particularly notable because the 
participants who were mandated to treatment were selected because their higher risk scores. So, 
when the highest risk patients showed a decrease in medical claims as compared to the lower risk 
tau group, it raises the consideration that a group treatment for patients with chronic pain may 
have the potential to impact medical costs. Taken together, group therapy is associated with 
decreasing spending patterns on pain. Therefore researchers rejected the null hypothesis 
regarding patient spending. 
Limitations 
 This study was most limited by the small sample size and lack of a true control group, 
given that patients were mandated into the treatment group. The sample size and lack of 
randomly assigned treatment intervention prevented researchers from drawing direct and 
generalizable causal conclusions regarding patient wellness as a function of attending group 
therapy. Other limitations included proration of test scores, standard pitfalls of subjective patient 
self-report, time variability in screener completion, and potentially negative contagion 
influencing patient health screener scores.  
Recommendations for the Clinic 
Perhaps most relevant for sustaining the gains made by the Pain Pathway, research and 
program evaluation models has shown that clinics are more likely to have successful outcome, 
and more engagement in sustaining the related processes when they have a clear implementation 
plan to launch a new program (Moise et al., 2018). As such, the clinic would likely benefit from 
having a designated care manager for pain patients while being open to renegotiating their 
policies regarding pain care in response to ongoing program assessment. The program may also 
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benefit from reducing the number of screeners and pages overall in the pain packets. This 
reduction would ideally minimize frustration felt by participants of the Pain Pathway that are 
already distressed. In addition, staff could encourage participants to engage in individual therapy 
to supplement material covered in group therapy and more importantly treat and monitor any 
significant mood changes. Lastly, clinicians could caution clients that they may not experience 
immediate improvement as they progress through the stages of group therapy and that continuing 
to experience some pain does not necessarily equate to their condition worsening.  
Recommendations for Future Studies 
Future researchers would benefit from redesigning the experiment so that it included true 
control and experimental groups via random selection and assignment. As the field moves more 
toward the Quadruple Aim, assessing provider satisfaction as well as patient outcome and patient 
satisfaction would strengthen conclusions regarding the potentially positive impact of a group 
intervention for patients with chronic pain. 
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● Coordinate	paperwork	with	insurance	companies	toward	requesting	psychological	testing	for	patients.		
Pre-Practicum	II,	George	Fox	University	 	 	 	 	 						January	2016–	May	2016	
Newberg,	Or	
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Teacher	Assistant	for	PsyD	512	Statistics																																													 	 	 	 Fall	2018	
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Guest	lecture	for	Psyc	150	General	Psychology																		 		 	 											 												Spring	2017	
Deliver	comprehensive	lecture	appropriate	to	introductory	level	psychology	undergraduate	students	about	the	
brain	with	regard	to	structure	and	subsequent	behavior.	
	
Teacher	Assistant	for	PsyD	552	Cognitive	Behavioral	Therapy							 	 			 			Fall	2017	
Demonstrate	and	guest	lecture	on	schema	therapy	and	ACT	for	graduate	level	students.	
	
Teacher	Assistant	for	Psyc	382	Advanced	Counseling	Skills			 	 												Fall	2017,	Fall	2018	
Assess	and	monitor	the	ongoing	development	of	undergraduate	students’	counseling	skills	while	utilizing	
bidirectional	feedback	to	maximize	this	process.		
Relevant	Work/Volunteer	Experience	
ACT	For	Business		 	 	 	 	 	 	 	 				October	2018-May	2019	
Provide	local	businesses	an	overview	of	mindfulness	and	values	guided	decision	making	training	designed	to	
increase	what	ACT	calls	“Psychological	Flexibility”.	
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● Conduct	a	one-hour	presentation	to	the	non-teaching/support	staff	of	Tualatin	Independent	School	District	during	an	in-service	training	day	on	October	12,2018.	
● Guide	participants	in	mindful	eating	exercise	to	encourage	mindfulness	practices.	
● Emphasize	that	the	program	is	dedicated	to	healthier	employees,	not	more	productive	employees	though	increases	in	productivity	often	accompany	improvements	in	health.	
● Provide	multiple	metaphors	that	capture	the	utility	and	essence	of	mindfulness,	such	as	“Leaves	on	a	stream”.		
Psychometrician	for	Dr.	Gary	Monkarsh’s,	Ph.D.,	Private	Practice																																					June	2018-Present	
A	private	practice	that	specializes	in	ADHD	and	PTSD	evaluations	across	the	lifespan.	
● Work	with	other	colleagues	and	the	owner	of	the	practice	to	schedule	patients	with	limited	space	and	time.	
● Dictate	test	results	and	behavioral	observations	for	a	transcriptionist	to	type	and	redirect	to	the	licensed	psychologist	for	writing	purposes.	
● Administer	cognitive,	achievement,	attention,	and	malingering	tests.		
Friendsview	Retirement	Community																																																																																	June	2016-January	2017	
Volunteer	at	a	retirement	community	for	adults	over	65	years	old	needing	from	little	to	constant	care.	Provides	
technical	support	and	engages	in	community-wide	activities.	
● Conduct	interviews	with	residents	and	upload	their	stories	to	an	archive	for	residents’	family	members	to	access.	
● Plan	a	group	for	bereavement	that	enables	residents	to	grieve	loved	ones	and	process	the	transition	into	assisted	living.	
● Offer	IT	support	to	residents	in	the	technology	lab.		
Mental-Health	Technician	at	the	Regional	Crisis	Response	Center																														May	2014	–May	2015																																																
Provide	specialized	care	for	adults	needing	24-hour	inpatient	psychiatric	care	offering	psychiatric	
interventions,	medication	stabilization,	cognitive	therapy,	stress	management,	anxiety	and	depression	
education,	and	group	therapy.	Located	in	Kilgore,	TX.	Supervisors:	Jeffery	Quiett	Ph.D.,	Ashley	Bing,	M.A.		
● Conduct	intake	screens	according	to	protocol,	uphold	the	therapeutic	milieu,	tend	to	client	comfort	and	transport,	measure	and	report	client’s	vital	signs,	and	maintain	facility	cleanliness.	
● Lead	group	therapy	sessions	about	hope,	depression,	and	bereavement.		
● Consult	with	supervisors	and	members	of	a	multidisciplinary	clinical	team	that	involved	nurses,	physicians,	psychiatrists,	and	psychologists.		
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Dissertation	
Studying	the	effectiveness	of	group	therapy	on	chronic	pain:	A	program	evaluation		 	The	study	sought	to	evaluate	the	effectiveness	of	group	therapy	with	respect	to	how	it	conducted	at	a	rural	medical	clinic	in	McMinville,	Oregon.	The	preliminary	defense	of	this	proposal	was	conducted	on	May	17,	2017.	The	final	defense	was	conducted	on	May	8,	2019.	
Invited	Presentations	Meguro,	L.,	Weeks,	T.,	Summers,	W.,	Roid,	G.,	Bufford,	R.	(2018,	May).	Nonverbal	cognitive	assessment	for	special-needs	or	non-English	ADHD	or	LD	cases.	Poster	presented	at	the	Western	Psychological	Association	(WPA).	Portland	OR.		
Summers,	W.	(2017,	November).	The	effectiveness	of	the	Pain	Pathway	at	Physicians	Medical	Center:	A	program	evaluation.	Presented	at	Pain	Summit	4.0.	McMinville,	OR.		
Summers,	W.,	Wendler,	D.,	Neary,	T.	(2017,	January).	A	meta-analysis	of	ADHD	and	increased	risk	for	suicide.	Poster	presented	at	The	American	Professional	Society	of	ADHD	and	Related	Disorders	(APSARD).	Washington,	D.C..																																													
Professional	Affiliations	
Collaborative	Family	Healthcare	Assocation	(CFHA)	 	 	 	 								2017-	Present	Academic	organization	that	seeks	to	stimulate	the	exchange	of	scientific	and	Professional	ideas	for	those	interested	in	behavioral	sciences.	
	
Western	Psychological	Assocation	(WPA)	 	 	 	 	 	 							2017-	Present	Academic	organization	that	seeks	to	stimulate	the	exchange	of	scientific	and	Professional	ideas	for	those	interested	in	behavioral	sciences.	
	
Association	of	Contextual	Behavioral	Science	(ACBS)		 	 	 	 								2017-	Present	
Professional	organization	that	promotes	online	learning,	in-person	training	opportunities		
and	research	for	clinicians	interested	in	ACT,	RFT,	or	contextual	behavioral	science.		
American	Psychological	Association	(Student	Affiliate)																																																		2013	-	Present	
Scientific	and	professional	organization	that	represents	psychologists	in	the	USA	
Other	Affiliations	
Gender,	Sexuality,	and	Identity	Student	Interest	Group	 	 				 																	2015-2019	
*Student	leader	(September	2016-	May	2018)	
PsyD	student-led	organization	that	discusses	and	researches	human	sexuality	and	gender	identity		
Geriatric	Psychology	Student	Interest	Group	 	 	 	 	 	 	2016-	2017	
*Student	leader/Founder	(September	2016-	May	2017)	
PsyD	student-led	organization	that	investigates		the	aging	process	and	overall	experience	of	older	adults.	
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Selected	Trainings	and	Workshops	
Gender	and	Sexuality	Certificate	Course	 	 	 	 							October-December	2018	
	 Speaker:	Brooke	Kuhnhausen,	Ph.D.		 Site:	George	Fox	University	 	
	
Spiritual	Formation:	Looking	Closer	at	Soul-Care		 	 	 		September	2018	
	 Speaker:	Mark	McMinn,	Ph.D.,	Lisa	McMinn,	Ph.D.		 Site:	George	Fox	University	 	
	
Treating	Complex	Patients	with	Chronic	Pain	 	 	 	 						February	2018	
	 Speakers:	Nina	Hidalgo,	Ph.D.		 Site:	Portland	VA	Medical	Center	
	
Leadership	Training:	A	seminar	 	 	 	 	 	 				November	2017	
	 Speaker:	Mary	Dunn,	Ph.D.		 Site:	George	Fox	University	 	
	
Diversity	and	psychotherapy		 	 	 	 	 																		November	2017	
	 Speakers:	Jeff	Sordahl,	PsyD		 Site:	George	Fox	University		
Pain	Summit	4.0-	All	About	Opioids	 	 	 	 	 	 				November	2017	
	 Speakers:	Bill	Koenig,	D.O.,	Representative	Ron	Noble,		Dwight	Holton	(former	Attorney	General),	Kody	Quinlan,	Mary	Borges,	Ph.D.,	Cory	Bradly,	Pharm.D.,	Will	Summers,	M.A.,			 Site:	Grand	Ballroom,	McMinville	OR	
	
ACT	II-	Seattle	 	 	 	 	 	 	 	 	 								October	2017	
	 Speaker:	Steve	Hayes,	Ph.D.		 Site:	Marriott	Inn,	Seattle	WA	
Languages	
● English	 	 	 	 	 	 	 	 		 										Native	Proficiency	
● Spanish	 	 	 	 	 	 	 																	Limited	Working	Proficiency	
 
